BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 2020;5:228. [PMID: 33028808 DOI: 10.1038/s41392-020-00313-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Hass R, von der Ohe J, Ungefroren H. Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness. Cancers (Basel) 2020;12:E3716. [PMID: 33322354 DOI: 10.3390/cancers12123716] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
2 Xu T, Junge JA, Delfarah A, Lu YT, Arnesano C, Iqbal M, Delijani K, Hsieh TC, Hodara E, Mehta HH, Cohen P, Graham NA, Fraser SE, Goldkorn A. Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time. Sci Rep 2022;12:5518. [PMID: 35365706 DOI: 10.1038/s41598-022-09438-9] [Reference Citation Analysis]
3 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
4 Cheng WL, Feng PH, Lee KY, Chen KY, Sun WL, Van Hiep N, Luo CS, Wu SM. The Role of EREG/EGFR Pathway in Tumor Progression. Int J Mol Sci 2021;22:12828. [PMID: 34884633 DOI: 10.3390/ijms222312828] [Reference Citation Analysis]
5 Jeong KY, Park MH. The Significance of Targeting Poly (ADP-Ribose) Polymerase-1 in Pancreatic Cancer for Providing a New Therapeutic Paradigm. Int J Mol Sci 2021;22:3509. [PMID: 33805293 DOI: 10.3390/ijms22073509] [Reference Citation Analysis]
6 Jiménez-Salazar JE, Damian-Ferrara R, Arteaga M, Batina N, Damián-Matsumura P. Non-Genomic Actions of Estrogens on the DNA Repair Pathways Are Associated With Chemotherapy Resistance in Breast Cancer. Front Oncol 2021;11:631007. [PMID: 33869016 DOI: 10.3389/fonc.2021.631007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang F, Huang H, Qin Y, Chen C, She L, Wang J, Huang D, Tang Q, Liu Y, Zhu G, Zhang X. MTDH associates with m6A RNA methylation and predicts cancer response for immune checkpoint treatment. iScience 2021;24:103102. [PMID: 34622157 DOI: 10.1016/j.isci.2021.103102] [Reference Citation Analysis]
8 Tang Y, Zhang Z, Chen Y, Qin S, Zhou L, Gao W, Shen Z. Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress. Antioxidants 2022;11:1324. [DOI: 10.3390/antiox11071324] [Reference Citation Analysis]
9 Tang Y, Chen Y, Zhang Z, Tang B, Zhou Z, Chen H. Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. Pharmaceutics 2021;13:2116. [PMID: 34959397 DOI: 10.3390/pharmaceutics13122116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
10 Jeong KY, Park MH. The Significance of Targeting Poly (ADP-Ribose) Polymerase-1 in Pancreatic Cancer for Providing a New Therapeutic Paradigm. Int J Mol Sci 2021;22:3509. [PMID: 33805293 DOI: 10.3390/ijms22073509] [Reference Citation Analysis]
11 Huang J, Chen S, Lin C. Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response. JPM 2022;12:556. [DOI: 10.3390/jpm12040556] [Reference Citation Analysis]
12 Liu Y, Wu H, Luo T, Luo Q, Meng Z, Shi Y, Li F, Liu M, Peng X, Liu J, Xu C, Tang W. The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer. Front Mol Biosci 2021;8:646542. [PMID: 34124145 DOI: 10.3389/fmolb.2021.646542] [Reference Citation Analysis]
13 Wang Z, Zhang H, Xu S, Liu Z, Cheng Q. The adaptive transition of glioblastoma stem cells and its implications on treatments. Signal Transduct Target Ther 2021;6:124. [PMID: 33753720 DOI: 10.1038/s41392-021-00491-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Haebe JR, Bergin CJ, Sandouka T, Benoit YD. Emerging role of G9a in cancer stemness and promises as a therapeutic target. Oncogenesis 2021;10:76. [PMID: 34775469 DOI: 10.1038/s41389-021-00370-7] [Reference Citation Analysis]
15 Wesley T, Berzins S, Kannourakis G, Ahmed N. The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence. Cell Commun Signal 2021;19:55. [PMID: 34001250 DOI: 10.1186/s12964-021-00726-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Foglietta F, Panzanelli P, Serpe L, Canaparo R. Exploiting Shock Waves to Trigger the Anticancer Sonodynamic Activity of 5-Aminolevulinc Acid-Derived Protoporphyrin IX on In Vitro 2D and 3D Cancer Models. Biomedicines 2022;10:615. [DOI: 10.3390/biomedicines10030615] [Reference Citation Analysis]
17 Champagne A, Jain P, Vélot L, Riopel J, Lefebvre V, Neveu B, Pouliot F. A transcriptional biosensor to monitor single cancer cell therapeutic responses by bioluminescence microscopy. Theranostics 2022;12:474-92. [PMID: 34976196 DOI: 10.7150/thno.63744] [Reference Citation Analysis]
18 Xavier CP, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, Vasconcelos MH. The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu J, Ding Y, Wang J, Lyu F, Tang Q, Song J, Luo Z, Wan Q, Lan X, Xu Z, Chen L. Single‐cell RNA sequencing in oral science: Current awareness and perspectives. Cell Proliferation. [DOI: 10.1111/cpr.13287] [Reference Citation Analysis]
20 Antoszczak M, Müller S, Cañeque T, Colombeau L, Dusetti N, Santofimia-Castaño P, Gaillet C, Puisieux A, Iovanna JL, Rodriguez R. Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells. J Am Chem Soc 2022. [PMID: 35696539 DOI: 10.1021/jacs.2c03973] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Di Vito Nolfi M, Vecchiotti D, Flati I, Verzella D, Di Padova M, Alesse E, Capece D, Zazzeroni F. EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player? Front Oncol 2022;12:933922. [DOI: 10.3389/fonc.2022.933922] [Reference Citation Analysis]
22 Tata A, Chow RD, Tata PR. Epithelial cell plasticity: breaking boundaries and changing landscapes. EMBO Rep 2021;22:e51921. [PMID: 34096150 DOI: 10.15252/embr.202051921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Saxena K, Subbalakshmi AR, Kulkarni P, Jolly MK. Cancer: More than a geneticist’s Pandora’s box. J Biosci 2022;47. [DOI: 10.1007/s12038-022-00254-x] [Reference Citation Analysis]
24 Belkhir S, Thomas F, Roche B. Darwinian Approaches for Cancer Treatment: Benefits of Mathematical Modeling. Cancers (Basel) 2021;13:4448. [PMID: 34503256 DOI: 10.3390/cancers13174448] [Reference Citation Analysis]
25 Mukherjee S, Heng HH, Frenkel-Morgenstern M. Emerging Role of Chimeric RNAs in Cell Plasticity and Adaptive Evolution of Cancer Cells. Cancers (Basel) 2021;13:4328. [PMID: 34503137 DOI: 10.3390/cancers13174328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhang Z, Qin S, Chen Y, Zhou L, Yang M, Tang Y, Zuo J, Zhang J, Mizokami A, Nice EC, Chen HN, Huang C, Wei X. Inhibition of NPC1L1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy. EMBO Mol Med 2022;:e14903. [PMID: 35023619 DOI: 10.15252/emmm.202114903] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
27 Weng N, Qin S, Liu J, Huang X, Jiang J, Zhou L, Zhang Z, Xie N, Wang K, Jin P, Luo M, Peng L, Nice EC, Goel A, Han S, Huang C, Zhu Q. Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.018] [Reference Citation Analysis]
28 De Silva F, Alcorn J. A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer. Cancers (Basel) 2022;14:2954. [PMID: 35740617 DOI: 10.3390/cancers14122954] [Reference Citation Analysis]
29 Ha JH, Jayaraman M, Yan M, Dhanasekaran P, Isidoro C, Song YS, Dhanasekaran DN. GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules 2021;11:1211. [PMID: 34439877 DOI: 10.3390/biom11081211] [Reference Citation Analysis]
30 El Sayed R, Blais N. Immunotherapy in Extensive-Stage Small Cell Lung Cancer. Curr Oncol 2021;28:4093-108. [PMID: 34677265 DOI: 10.3390/curroncol28050347] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 2021;13:3602. [PMID: 34298815 DOI: 10.3390/cancers13143602] [Reference Citation Analysis]
32 Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh MT, Waseem A. Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers (Basel) 2021;13:4985. [PMID: 34638469 DOI: 10.3390/cancers13194985] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Tu SM, Zhang M, Wood CG, Pisters LL. Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. Cancers (Basel) 2021;13:4006. [PMID: 34439162 DOI: 10.3390/cancers13164006] [Reference Citation Analysis]
34 Milton AV, Konrad DB. Epithelial-mesenchymal transition and H2O2 signaling - a driver of disease progression and a vulnerability in cancers. Biol Chem 2022. [PMID: 35032422 DOI: 10.1515/hsz-2021-0341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Lavallee E, Sfakianos JP, Mulholland DJ. Tumor Heterogeneity and Consequences for Bladder Cancer Treatment. Cancers (Basel) 2021;13:5297. [PMID: 34771460 DOI: 10.3390/cancers13215297] [Reference Citation Analysis]
36 Hass R, von der Ohe J, Ungefroren H. The Intimate Relationship Among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes. Cancers (Basel) 2020;12:E3674. [PMID: 33297508 DOI: 10.3390/cancers12123674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
37 Ming H, Li B, Zhou L, Goel A, Huang C. Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications. Biochim Biophys Acta Rev Cancer 2021;1875:188519. [PMID: 33548345 DOI: 10.1016/j.bbcan.2021.188519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]